Immunocompromised patients and COVID-19: how do we protect those most at risk?

被引：3
|
作者：
Schneider, Jochen [1 ]
Erber, Johanna [1 ]
Renders, Lutz [2 ]
Spinner, Christoph D. [1 ]
机构：
[1] Univ Hosp Klinikum Rechts der Isar, Sch Med, Dept Internal Med 2, Infect Dis, Munich, Germany
[2] Univ Hosp Klinikum Rechts der Isar, Sch Med, Dept Internal Med 2, Nephrol, Munich, Germany
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2024年 / 22卷 / 1-3期
关键词：
COVID-19; immunosuppression; risk for severe COVID-19; ORGAN TRANSPLANT RECIPIENTS;
D O I：
10.1080/14787210.2023.2296067
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [21] COVID-19; beyond the obvious: how do we move forward?
    Afshin Nasoodi
    Ciaran Johnston
    Francesco Fraioli
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2070 - 2071
  • [22] How do we teach surgical residents in the COVID-19 era?
    Okland, Tyler S.
    Pepper, Jon-Paul
    Valdez, Tulio A.
    JOURNAL OF SURGICAL EDUCATION, 2020, 77 (05) : 1005 - 1007
  • [23] COVID-19 vaccines: how did we do so well?
    Riley, Eleanor M.
    TRENDS IN UROLOGY & MENS HEALTH, 2021, 12 (03) : 20 - 22
  • [24] INTRODUCTION: COVID-19 and Aging Bodies - What Do We Mean When We Say That Older Adults Are Most 'Affected' by COVID-19?
    Verbruggen, Christine
    ANTHROPOLOGY & AGING, 2020, 41 (02): : 126 - 131
  • [25] Genetics and COVID-19: How to Protect the Susceptible
    Field, Robert I.
    Orlando, Anthony W.
    Rosoff, Arnold J.
    TRENDS IN GENETICS, 2021, 37 (02) : 106 - 108
  • [26] New Guidance Helps Clinicians Use Pemivibart to Protect Immunocompromised Patients From COVID-19
    Bock, Anna
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (14): : 1127 - 1129
  • [27] How do we do culture next? Cultural districts in times of COVID-19
    Jurkute, Vilma
    TOWN PLANNING REVIEW, 2021, 92 (03): : 359 - 364
  • [28] Elective lung cancer surgery in the COVID-19 era: how do we do it?
    Bilkhu, Rajdeep
    Bille, Andrea
    TUMORI JOURNAL, 2020, 106 (03): : 190 - 192
  • [29] Promoting coronavirus disease 2019 (COVID-19) vaccination: Do we need to reframe how we present risk?
    Doll, Michelle
    Guidry, Jeanine P. D.
    Pryor, Rachel
    Kellermann, Arthur L.
    Stevens, Michael P.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (10): : 1530 - 1530
  • [30] COVID-19 Adverse Outcomes in Immunocompromised Patients
    Shabani, Shiva
    Cheraghi, Parvaneh
    Ghaffari-Nazari, Haniyeh
    Hajifathali, Abbas
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2023, 16 (01)
12345